PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Est. Return
73.17%
1 Year Est. Return
+73.17%
AUM
$2.67B
AUM Growth
-$155M
(-5.5%)
Holding
105
Top Buys
| 1 | +$166M | |
| 2 | +$44.4M | |
| 3 | +$37.5M | |
| 4 |
CAI
Caris Life Sciences
CAI
|
+$29.3M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$19.5M |
Top Sells
| 1 | +$104M | |
| 2 | +$99.9M | |
| 3 | +$90.2M | |
| 4 |
Amicus Therapeutics
FOLD
|
+$80.5M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$42.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
SPDR S&P Biotech ETF
XBI
$6.24B
| – | – |
0
|
|
||
102
Traws Pharma
TRAW
$20.4M
| – | – |
-421,781
|
|
||
|
OKUR
103
OnKure Therapeutics
OKUR
$37.6M
| – | – |
-1,004,439
|
|
||
|
KMTS
104
Kestra Medical Technologies
KMTS
$1.27B
| – | – |
-200,000
|
|
||
|
ITCI
105
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-786,358
|
|